Division of Infectious Diseases

The Division of Infectious Diseases provides consultation in the diagnosis and management of infectious diseases in children – especially recurrent, rare, or difficult to treat infections, including HIV/AIDS.

Consultative services are provided for children with:

Physicians also conduct follow-up for children admitted to Children's Hospital for infections. In addition, they assist in the laboratory diagnosis of infections and in the selection of therapeutic and preventive strategies including antimicrobials, vaccines, and immunoglobulins. Consultation is available for international travelers.

Referral Requirements

Referrals are not required from primary care physicians or other Children’s Hospital specialty services. Referrals for patients enrolled in managed care insurance plans may require authorization from the insurance provider and primary care physician. We strongly recommend that you consult with your primary physician to ensure that a visit to the Infectious Disease clinic will be beneficial for your child. In addition, notes and lab results should be sent from your primary physician’s office to our clinic before the visit so we can provide the best care for your child. All necessary referral and authorization forms must be received before the patient’s visit. For accurate provider numbers or more information, please call the office number listed.



Clinical Trials

  • Infectious Diseases

    UPMC Children's Hospital of Pittsburgh
    4401 Penn Avenue
    Floor 3
    Pittsburgh, PA 15224
  • Children's North

    2599 Wexford Bayne Rd.
    Sewickley, PA 15143
  • Acute Gastroenteritis (AGE) and Acute Respiratory Illness (ARI) in Children

    Enhanced Active Surveillance of Pediatric Infectious Disease and Vaccine by the New Vaccine Surveillance Network

    Read more

    Candidiasis Treatment with Anidulafungin

    A Study to Assess the Pharmacokinetics, Safety and Efficacy of Anidulafungin When Used to Treat Children with Invasive Candidiasis, Including Candidemia

    Read more

    Candidiasis Treatment with Micafungin in Neonates – Phase III

    A Study to Compare the Efficacy and Safety of Micafungin Versus Amphotericin B Deoxycholate for the Treatment of Neonatal Candidiasis

    Read more

    Clostridium Difficile-Associated Diarrhea Treatment with Fidaxomicin – Phase IIa

    Study to Determine the Safety, Tolerability and Pharmacokinetics of Fidaxomicin Oral Suspension or Tablets in Pediatric Subjects with Clostridium Difficile-associated Diarrhea (CDAD)

    Read more

    Influenza Treatment in Immunocompromised Patients – Phase IV

    Treatment of Immunocompromised Patients with Conventional and High Dose Oseltamivir

    Read more

    Influenza Treatment with Zanamivir for Hospitalized Patients

    Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirmed Influenza Infection

    Read more

    Respiratory Fungal Infection Treatment with Voriconazole – Phase II

    Voriconazole as Therapy for Treatment of Invasive Aspergillosis and Molds

    Read more